Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 38.5a

10 Nov 2015 12:05

RNS Number : 2027F
GoldmanSachs International
10 November 2015
 

Ap24

 

FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

(GS) GOLDMAN SACHS INTERNATIONAL

Company dealt in

PFIZER INC

Class of relevant security to which the dealings being disclosed relate (Note 1)

USD Ordinary

Date of dealing

09 November 2015

 

2. DEALINGS (Note 2)

 

(a) Purchases and sales

 

Total number of relevant securities acquired

Highest price paid (Note 3)

Lowest price paid

(Note 3)

132,857

33.6424 USD

33.6100 USD

 

Total number of securities disposed

Highest price received (Note 3)

Lowest price received

(Note 3)

132,857

33.6424 USD

33.6424 USD

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 4)

Number of relevant securities

(Note 5)

Price per unit

(Note 3)

 

Ap25

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)

Call Option / (1.00 : 100.00)

Selling

2 (200)

35.0000 USD

AMERICAN

20/11/2015

0.1400 USD

Put Option / (1.00 : 100.00)

Purchasing

4 (400)

32.0000 USD

AMERICAN

20/11/2015

0.1100 USD

Put Option / (1.00 : 100.00)

Selling

36 (3,600)

33.0000 USD

AMERICAN

18/12/2015

0.7300 USD

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)

Call Warrant

Purchasing

12,000

32.0000 USD

AMERICAN

18/03/2016

0.2700 EUR

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 3)

 

3.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securitiesunder any option referred to on this form or relating to the voting rights or future acquisitionor disposal of any relevant securities to which any derivative referred to on this form is referenced.If none, this should be stated.

 

 

 

 

Date of disclosure

10 November 2015

Contact name

Aadithya Rao and Yiannis Bardis

Telephone number

+44(20) 7051 9046 / +44(20) 7774 7107

Name of offeree/offeror with which connected

Pfizer Inc

Nature of connection (Note 6)

Advisor to Offeror

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEEAAFEFEDSFFF
Date   Source Headline
13th Nov 20155:08 pmRNSForm 8.3 - Pfizer, Inc.
13th Nov 20155:05 pmRNSForm 8.3 - Pfizer, Inc.
13th Nov 20153:33 pmRNSForm 8.3 - Allergan plc
13th Nov 20153:26 pmRNSForm 8.3 - Pfizer Inc
13th Nov 20153:26 pmRNSForm 8.3 - Pfizer Inc
13th Nov 20153:26 pmRNSForm 8.3 - PFIZER INC
13th Nov 20153:17 pmRNSForm 8.3 - Pfizer Inc.
13th Nov 20153:12 pmRNSForm 8.3 - [PFIZER INC]
13th Nov 20152:59 pmBUSForm 8.3 - Pfizer Inc.
13th Nov 20152:45 pmRNSForm 8.3 - Pfizer Inc
13th Nov 20152:40 pmRNSForm 8.3 - ALLERGAN PLC
13th Nov 20152:37 pmRNSForm 8.3 - Allergan Plc
13th Nov 20151:57 pmRNSForm 8.3 - Allergan plc
13th Nov 201512:10 pmRNSForm 38.5b
13th Nov 201512:07 pmRNSForm 38.5b
13th Nov 201512:05 pmRNSForm 38.5a
13th Nov 201512:03 pmRNSForm 8.1 - [Pfizer Inc]
13th Nov 201511:55 amRNSForm 8.1(a) - Pfizer Inc.
13th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
13th Nov 201511:47 amRNSForm 38.5(a) - Pfizer Inc.
13th Nov 201511:40 amRNSForm 38.5(b) - Pfizer Inc.
13th Nov 201511:05 amRNSRule 38.5 - Pfizer INC
13th Nov 201511:04 amRNSRule 38.5 - Pfizer INC
13th Nov 201511:02 amRNSRule 38.5 - Pfizer INC
13th Nov 20157:00 amRNSForm 8.3 - Pfizer Inc - Replacement
12th Nov 20153:37 pmRNSForm 8.3 - ALLERGAN PLC
12th Nov 20153:30 pmRNSForm 8.3 - Allergan plc
12th Nov 20153:29 pmRNSForm 8.3 - Pfizer Inc
12th Nov 20153:27 pmRNSForm 8.3 - Pfizer Inc
12th Nov 20153:14 pmRNSForm 8.3 - [PFIZER INC]
12th Nov 20153:05 pmRNSForm 8.3 - PFIZER INC
12th Nov 20153:05 pmRNSForm 8.3 - Pfizer, Inc.
12th Nov 20152:58 pmRNSForm 8.3 - Pfizer Inc
12th Nov 20152:53 pmRNSRule 38.5 - Replacement Pfizer INC
12th Nov 20152:44 pmRNSForm 8.3 - Allergan Plc
12th Nov 20152:16 pmRNSForm 38.5(b) - Pfizer Inc Amendment
12th Nov 20151:56 pmRNSForm 8.3 - Allergan plc
12th Nov 201511:56 amRNSForm 38.5a
12th Nov 201511:55 amRNSForm 8.3 - Pfizer, Inc.
12th Nov 201511:54 amRNSForm 8.1 - [Pfizer Inc]
12th Nov 201511:51 amRNSForm 38.5(b) - Pfizer Inc.
12th Nov 201511:49 amRNSForm 38.5(a) - Pfizer Inc
12th Nov 201511:09 amRNSRule 38.5 - Pfizer INC
12th Nov 201511:06 amRNSRule 38.5 - Pfizer INC
11th Nov 20153:33 pmRNSForm 8.3 - Pfizer Inc
11th Nov 20153:19 pmRNSForm 8.3 - [PFIZER INC]
11th Nov 20153:11 pmRNSForm 8.3 - ALLERGAN PLC
11th Nov 20153:09 pmRNSForm 8.3 - PFIZER INC
11th Nov 20153:09 pmRNSForm 8.3 - Pfizer, Inc.
11th Nov 20153:06 pmRNSForm 8.3 - Pfizer Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.